| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.03. | Tenon Medical, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 19.03. | Tenon Medical outlines growth acceleration plans following 92% Q4 revenue jump and expanded SI-Joint Fusion portfolio | 1 | Seeking Alpha | ||
| 19.03. | Tenon Medical GAAP EPS of -$0.29 beats by $0.07, revenue of $1.5M beats by $0.12M | 2 | Seeking Alpha | ||
| 19.03. | Tenon Medical, Inc.: Tenon Medical Reports Fourth Quarter and Full Year 2025 Financial Results | 584 | ACCESS Newswire | ~ Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second... ► Artikel lesen | |
| 19.03. | Tenon Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.03. | Tenon Medical raises $4.3M through convertible note offering | 3 | Investing.com | ||
| TENON MEDICAL Aktie jetzt für 0€ handeln | |||||
| 12.03. | Tenon Medical raises $4.3M via convertible note offering | 2 | Investing.com | ||
| 12.03. | Tenon Medical nimmt 4,3 Mio. US-Dollar durch Privatplatzierung von Wandelanleihen ein | 6 | Investing.com Deutsch | ||
| 12.03. | Tenon Medical, Inc.: Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million | 410 | ACCESS Newswire | LOS GATOS, CA / ACCESS Newswire / March 12, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders... ► Artikel lesen | |
| 18.02. | Tenon Medical stärkt Patentportfolio mit neuen US-Zulassungen | 2 | Investing.com Deutsch | ||
| 18.02. | Tenon Medical expands patent portfolio with new USPTO allowances | 6 | Investing.com | ||
| 18.02. | Tenon Medical, Inc.: Tenon Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion | 405 | ACCESS Newswire | Expanded Global Portfolio Enhances Competitive Position and Supports Long-Term Growth Strategy LOS GATOS, CA / ACCESS Newswire / February 18, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the... ► Artikel lesen | |
| 12.02. | Tenon Medical, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 06.02. | Tenon Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.02. | Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues | 290 | ACCESS Newswire | Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over yearFull Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year LOS GATOS... ► Artikel lesen | |
| 28.01. | Tenon Medical reports 90% revenue growth in Q4 2025 | 2 | Investing.com | ||
| 28.01. | Tenon Medical, Inc.: Tenon Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025 | 360 | ACCESS Newswire | Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over year.Full Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year. LOS GATOS... ► Artikel lesen | |
| 04.12.25 | Tenon Medical, Inc.: Tenon Medical Announces Successful Completion of Initial Cases with New SImmetry+ SI Joint Fusion System | 1.983 | ACCESS Newswire | ~ Procedures Completed in Various Spine Centers of Excellence Throughout the Country Including Florida, Arizona, Ohio, and Texas ~~ SImmetry+ combines 3D-printed titanium implants, a robust joint decorticator... ► Artikel lesen | |
| 17.11.25 | Tenon Medical, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Tenon Medical raises $2.85 million in private placement | 6 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,620 | +0,97 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
16.04.2026 /... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,910 | +1,46 % | Abspaltung der Siemens-Medizintechnik Healthineers erst im Jahr 2027 | DJ Abspaltung der Siemens-Medizintechnik erst im Jahr 2027
DOW JONES--Die Abspaltung der Siemens-Medizintechnik vom Mutterkonzern wird erst im nächsten Jahr stattfinden. Die Siemens-Aktionäre... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,840 | +0,36 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| UNITEDHEALTH | 275,00 | -0,29 % | Unitedhealth mit Rekordsignal: Was große Adressen zum Wochenstart bereits wissen - Was erfahrene Anleger jetzt analysieren | ||
| GERRESHEIMER | 21,320 | +0,85 % | Shortseller-Positionen aktuell: u.a. Auto1, CTS Eventim, Gerresheimer, HelloFresh, Hugo Boss, Kontron, TUI, Zalando | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| MEDTRONIC | 73,04 | -0,27 % | Truist Cuts Medtronic (MDT) Price Target, Sees Stable Q1 Performance | ||
| HIMS & HERS HEALTH | 24,500 | +0,08 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -21,43 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| VERU | 2,460 | +0,82 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,955 | -12,72 % | Tempest Therapeutics: Tempest Reports Year End 2025 Financial Results and Provides Business Update | Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the ongoing... ► Artikel lesen | |
| TENET | 169,00 | +1,20 % | Cantor Fitzgerald bestätigt Rating für Tenet Healthcare aufgrund von Volumendaten | ||
| PANGENOMIC HEALTH | 0,231 | -6,48 % | XFRA LL3: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPANGENOMIC HEALTH... ► Artikel lesen | |
| SOMNIGROUP INTERNATIONAL | 71,60 | -0,86 % | Somnigroup International, the World's Leading Bedding Company, to Acquire Leggett & Platt, A Diversified Component Manufacturer and Key Somnigroup Supplier, in an All-Stock Transaction | - Continues vertical integration strategy, enhancing consumer-centric innovation
- Expands addressable market in bedding and into non-bedding industries
- Reduces... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 2,670 | +0,75 % | SINTX Technologies, Inc.: SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution | Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 2,635 | -2,41 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified | NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen |